Original paper
Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin
Abstract
Patient-reported symptoms correlate poorly with mucosal inflammation. Clinical decision-making may, therefore, not be based on objective evidence of disease activity. We conducted a study to determine factors associated with clinical decision-making in a secondary care inflammatory bowel disease (IBD) population, using a cross-sectional design.Decisions to request investigations or escalate medical therapy were recorded from outpatient clinic...
Paper Details
Title
Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin
Published Date
Jan 1, 2018
Volume
11